Genome-wide CRISPR screens reveal cyclin C as synthetic survival target of BRCA2 is a research paper published in Nucleic Acids Research (2021). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Prevention and Research Institute of Texas
Grant: RP180813
CPRIT
Grant: RP160667
National Institutes of Health
Grant: R01CA210929
National Institutes of Health
Grant: R01CA216911
National Institutes of Health
Grant: R01CA216437
MD Anderson
Grant: P30CA016672
UTHealth Cancer Genomics Core
Grant: RP180734
Pamela and Wayne Garrison Distinguished Chair in Cancer Research
FWCI
2.78
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 1 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 8 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 8 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 4 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 5 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 7 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 5 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 4 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 9 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 2 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 7 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 3 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 6 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 6 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 2 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 9 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors
Additional file 3 of Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors